Month: January 2020

It’s hard to forecast exactly how a specific stock will perform over just a 12-month period, let alone over five years. This is especially true for smaller biotech stocks, where

Innovative Industrial Properties (IIPR) has started off 2020 with another capital raise as they look to continue to grow their already impressive portfolio of cannabis-related real estate. The company announced

After tumbling nearly 5% in Monday trading, shares of Canadian cannabis company Canopy Growth (NYSE:CGC) rebounded Tuesday, closing the day up 11%…

A disagreement between two Canadian cannabis companies is headed to court. Medipharm Labs (OTC:MEDIF) said in a tersely worded press release Friday that one of its subsidiaries has filed a legal claim against

Comparing any stock to a ship probably isn’t the best analogy. However, I couldn’t help thinking of the Titanic after seeing some of the headlines over the last couple of months about Aurora

Cronos Group (NASDAQ:CRON) was once known as the best-performing marijuana stock of all time, and the good news for the company is that it performed better than many of its peers in 2019.

Why go for overbought FAANG stocks that have limited upside when you can buy a badly beaten cannabis industry that’s ripe for bottom-picking? After a strong start in 2019, the

It’s one of the most controversial names in the cannabis industry. Aurora Cannabis (NYSE:ACB) definitely has its fair share of detractors. But some think that Aurora could be one of the biggest

There’s a lot of controversy surrounding the effectiveness of cannabis. While many people will claim that it has helped treat conditions that no other drug could, there are also people